NCT00003631View on ClinicalTrials.gov

Chemotherapy Plus Radiation Therapy in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

118

Participants

Timeline

Start Date

August 31, 1998

Primary Completion Date

April 30, 2010

Conditions
Lymphoma
Interventions
BIOLOGICAL

filgrastim

DRUG

carboplatin

DRUG

carmustine

DRUG

cyclophosphamide

DRUG

cytarabine

DRUG

etoposide

DRUG

ifosfamide

DRUG

melphalan

PROCEDURE

bone marrow ablation with stem cell support

PROCEDURE

peripheral blood stem cell transplantation

RADIATION

radiation therapy

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00003631 - Chemotherapy Plus Radiation Therapy in Treating Patients With Refractory or Relapsed Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter